Xenon Pharmaceuticals Inc (XENE)
Operating Cash Flow Growth
-48.51%
Quarterly · Period ending:
XENE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-48.51%period ending
Latest reported-48.51%period ending
XENE Quarterly Cash from Operations YoY % (-74.75% → -48.51%)
Year-over-year change
High-resolution chart · PNG
XENE operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -48.5062% | |
| -44.1916% | |
| -49.8226% | |
| -44.472% | |
| -96.5574% | |
| -33.4834% | |
| -53.3484% | |
| -17.606% | |
| 1.6315% | |
| -34.2216% | |
| -8.3496% | |
| -38.9053% | |
| -96.9469% | |
| -86.7321% | |
| -58.0493% | |
| -102.5855% | |
| -28.9898% | |
| 11.0102% | |
| -57.9228% | |
| -25.3259% | |
| -25.244% | |
| -58.4755% | |
| -166.4505% | |
| -69.4407% | |
| -20.9455% | |
| -50.7673% | |
| 372.5076% | |
| 48.51% | |
| -55.8866% | |
| -5.4508% | |
| -5.9082% | |
| -59.112% | |
| 18.5828% | |
| -27.2291% | |
| -46.424% | |
| -90.672% | |
| -25.2901% | |
| -30.6634% | |
| 10.9968% | |
| 7.39% | |
| -123.9686% | |
| 10.8707% | |
| -77.8041% | |
| -177.7371% | |
| -8.9438% | |
| -558.7886% | |
| -9.866% | |
| 26.2354% | |
| 20.7339% | |
| 70.0036% | |
| -113.6252% | |
| -74.7483% |